Jubilant Biosys appoints Venugopala Reddy Pagadala as VP & CFO, CRDMO
Noida: Jubilant Biosys Limited, a subsidiary of Jubilant Pharmova, has announced the appointment of Venugopala Reddy Pagadala as VP & CFO, CRDMO.
Jubilant Biosys Ltd (JBL) offers end-to-end CRDMO solutions in Structural Biology, Computational Chemistry, Medicinal & Synthetic Chemistry, in-vitro and in-vivo Biology, DMPK, Toxicology, Process R&D & Manufacturing to various Biotech & Pharma companies pursuing drug discovery, development and manufacturing. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Pharmova, serving the global life sciences, agrochemicals and specialty chemicals industry through its research centers & manufacturing facilities in India. Jubilant’s services in discovery research include;
Jubilant’s services in discovery research includes;
• Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain and Inflammation.
• Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.
